Home › NDC Lookup › RxCUI directory › RxCUI 977978

Halobetasol propionate 0.0005 MG/MG Topical Ointment — RxCUI 977978

RxNorm drug concept · Semantic clinical drug
RxCUI 977978 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI977978
Official nameHalobetasol propionate 0.0005 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashalobetasol propionate 0.05 % Topical Ointment
FDA products mapped8
Package NDCs mapped13
Reported Medicaid activity (SDUD)28,315 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Halobetasol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Halobetasol topical is used to treat inflammatory skin conditions — conditions that cause redness, swelling, and itching. The ointment form is used broadly for skin conditions that...
  • You should use halobetasol topical for no longer than two consecutive weeks, and no more than 50 grams total per week. It's a very potent steroid, and using it longer or in larger...
  • Yes — avoid applying halobetasol to your face, groin, or underarms. These areas have thinner skin and absorb much more of the medication, increasing your risk of side effects. Also...
  • Are there places I should not apply this?
📖 Read our full Halobetasol Topical guide →

🕸️ Concept Web — How Halobetasol propionate 0.0005 MG/MG Topical Oint... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Halobetasol propionate 0.0005 MG/MG Topical Ointment RxCUI 977978

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Halobetasol 41208
    • Halobetasol propionate 45318
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ultravate 57766
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Halobetasol Topical Ointment 372372
    • Halobetasol propionate Topical Ointment 2648397
    • Halobetasol Topical Product 1158362
    • Halobetasol propionate Topical Product 2659417
    • Halobetasol Topical Ointment [Ultravate] 367313
    • Halobetasol propionate Topical Ointment [Ultravate] 2657906
    • Ultravate Topical Product 1187823
    • Topical Ointment 316985
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Halobetasol propionate 0.0005 MG/MG 884691
    • Halobetasol propionate 0.0005 MG/MG Topical Ointment [Ultravate] 977980
    • Halobetasol propionate 0.0005 MG/MG [Ultravate] 977979
  5. Packs 4

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {1 (225 ML) (ammonium lactate 120 MG/ML Topical Lotion [Lac-Hydrin]) / 1 (50 ML) (halobetasol propionate 0.0005 MG/MG Topical Ointment [Ultravate]) } Pack [Ultravate Pac] 978056
    • {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment] 1301696
    • {1 (225 ML) (ammonium lactate 120 MG/ML Topical Lotion) / 1 (50 ML) (halobetasol propionate 0.0005 MG/MG Topical Ointment) } Pack 978054
    • {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack 1301695

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Halobetasol propionate 0.0005 MG/MG SCDC · 884691
  • Halobetasol Topical Ointment SCDF · 372372
  • Halobetasol propionate Topical Ointment SCDFP · 2648397
  • Halobetasol Topical Product SCDG · 1158362
  • Halobetasol propionate Topical Product SCDGP · 2659417
  • {1 (225 ML) (ammonium lactate 120 MG/ML Topical Lotion) / 1 (50 ML) (halobetasol propionate 0.0005 MG/MG Topical Ointment) } Pack GPCK · 978054
  • {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack GPCK · 1301695

Brand-Name Concepts

  • Halobetasol propionate 0.0005 MG/MG Topical Ointment [Ultravate] SBD · 977980
  • Halobetasol propionate 0.0005 MG/MG [Ultravate] SBDC · 977979
  • Halobetasol Topical Ointment [Ultravate] SBDF · 367313
  • Halobetasol propionate Topical Ointment [Ultravate] SBDFP · 2657906
  • Ultravate Topical Product SBDG · 1187823
  • Ultravate BN · 57766
  • {1 (225 ML) (ammonium lactate 120 MG/ML Topical Lotion [Lac-Hydrin]) / 1 (50 ML) (halobetasol propionate 0.0005 MG/MG Topical Ointment [Ultravate]) } Pack [Ultravate Pac] BPCK · 978056
  • {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment] BPCK · 1301696

📦 FDA Products & Package NDCs

8 products · 13 package NDCs
13 package NDCs map to RxCUI 977978 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00713-0339-15 1 TUBE in 1 CARTON (0713-0339-15) / 15 g in 1 TUBE Halobetasol Propionate Cosette Pharmaceuticals, Inc. 2018-02-21
00713-0339-86 1 TUBE in 1 CARTON (0713-0339-86) / 50 g in 1 TUBE Halobetasol Propionate Cosette Pharmaceuticals, Inc. 2018-02-21
45802-0131-32 1 TUBE in 1 CARTON (45802-131-32) / 50 g in 1 TUBE Halobetasol Propionate Padagis Israel Pharmaceuticals Ltd 2009-02-05
45802-0131-35 1 TUBE in 1 CARTON (45802-131-35) / 15 g in 1 TUBE Halobetasol Propionate Padagis Israel Pharmaceuticals Ltd 2010-01-14
63629-8664-01 1 TUBE in 1 CARTON (63629-8664-1) / 15 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2010-01-14
63629-8665-01 1 TUBE in 1 CARTON (63629-8665-1) / 50 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2009-02-05
70752-0119-02 1 TUBE in 1 CARTON (70752-119-02) / 15 g in 1 TUBE Halobetasol Propionate QUAGEN PHARMACEUTICALS LLC 2020-10-06
70752-0119-04 1 TUBE in 1 CARTON (70752-119-04) / 50 g in 1 TUBE Halobetasol Propionate QUAGEN PHARMACEUTICALS LLC 2020-10-06
72162-1396-02 1 TUBE in 1 CARTON (72162-1396-2) / 15 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2024-03-11
72162-1396-04 1 TUBE in 1 CARTON (72162-1396-4) / 50 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2024-03-11
72162-2067-02 1 TUBE in 1 CARTON (72162-2067-2) / 15 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2023-08-15
72162-2067-04 1 TUBE in 1 CARTON (72162-2067-4) / 50 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2023-08-15
72162-2258-02 1 TUBE in 1 CARTON (72162-2258-2) / 50 g in 1 TUBE Halobetasol Propionate Bryant Ranch Prepack 2018-02-21
Observed labelers: Bryant Ranch Prepack (7) · Cosette Pharmaceuticals, Inc. (2) · Padagis Israel Pharmaceuticals Ltd (2) · QUAGEN PHARMACEUTICALS LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.5732
Range $0.4854–$0.6610 · middle 50% $0.4854–$0.6610 · 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.